Literature DB >> 29982747

Examining the impact of a multimedia intervention on treatment decision-making among newly diagnosed prostate cancer patients: results from a nationwide RCT.

Michael A Diefenbach1,2, Catherine Benedict1,2, Suzanne M Miller3, Annette L Stanton4, Mary E Ropka5, Kuang-Yi Wen3, Linda G Fleisher6, Nihal E Mohamed7, Simon J Hall8.   

Abstract

Men diagnosed with early stage prostate cancer face multiple treatment options, each with distinctive side effects that have significant implications for post-treatment quality of life. Healing Choices for Men with Prostate Cancer is a multimedia educational and decision aid program. This nation-wide randomized controlled trial evaluated the impact of Healing Choices on reducing decisional conflict and distress. Eligible prostate cancer patients who called the National Cancer Institute's Cancer Information Service (CIS) were invited to participate. After a baseline interview, participants were randomized to usual personalized consultation with a CIS specialist (comparison condition) or CIS personalized consultation plus the Healing Choices program (intervention condition). The Decision Conflict Scale and Impact of Event Scale assessed decisional conflict about prostate cancer treatment and cancer-related distress, respectively. Analyses evaluated group differences at 2 months postenrollment. Hypothesized moderation of intervention effects by demographic and clinical characteristics were evaluated. The final sample consisted of N = 349 participants (intervention: n = 181; comparison n = 168). Men were on average 64 years old, primarily White, and well educated. The difference in total decisional conflict was not significant (DCS total score; F[1,311] = .99, p = .32). The difference in cancer-related distress at 2 months between the intervention and the comparison groups was not significant (F[1,337] = .01, p = .93). Evaluation of specific decision processes indicated a significant effect on levels of perceived decisional support (intervention, M = 34.8, SD = 15.7; comparison, M = 38.3, SD = 16.1; F[1,337] = 3.74, p = .05). The intervention effect was greatest for nonwhite minority participants (b = -9.65, SE = 4.67) and those with lower educational attainment (b = 3.87, SE = 2.21). This interactive, comprehensive education and decision aid program may be most effective for a subset of prostate cancer patients in need of educational and decisional support.

Entities:  

Mesh:

Year:  2018        PMID: 29982747      PMCID: PMC6248862          DOI: 10.1093/tbm/iby066

Source DB:  PubMed          Journal:  Transl Behav Med        ISSN: 1613-9860            Impact factor:   3.046


  40 in total

Review 1.  Educational benefits of Internet and computer-based programmes for prostate cancer patients: a systematic review.

Authors:  Anne Salonen; Anne M Ryhänen; Helena Leino-Kilpi
Journal:  Patient Educ Couns       Date:  2013-08-30

2.  Human agency in social cognitive theory.

Authors:  A Bandura
Journal:  Am Psychol       Date:  1989-09

3.  Who makes the decision regarding the treatment of clinically localized prostate cancer--the patient or physician?: results from a population-based study.

Authors:  Lixin Song; Ronald C Chen; Jeannette T Bensen; George J Knafl; Matthew E Nielsen; Laura Farnan; Eric M Wallen; Merle Mishel; Raj S Pruthi; James L Mohler; Paul A Godley
Journal:  Cancer       Date:  2012-07-11       Impact factor: 6.860

Review 4.  Patient preferences for shared decisions: a systematic review.

Authors:  Betty Chewning; Carma L Bylund; Bupendra Shah; Neeraj K Arora; Jennifer A Gueguen; Gregory Makoul
Journal:  Patient Educ Couns       Date:  2011-04-06

5.  Psychological distress in cancer patients with advanced disease.

Authors:  S Kaasa; U Malt; S Hagen; E Wist; T Moum; A Kvikstad
Journal:  Radiother Oncol       Date:  1993-06       Impact factor: 6.280

Review 6.  Patient decision aids for prostate cancer treatment: a systematic review of the literature.

Authors:  Grace A Lin; David S Aaronson; Sara J Knight; Peter R Carroll; R Adams Dudley
Journal:  CA Cancer J Clin       Date:  2009-10-19       Impact factor: 508.702

Review 7.  Decision making and prostate cancer screening.

Authors:  Sara J Knight
Journal:  Urol Clin North Am       Date:  2014-02-28       Impact factor: 2.241

Review 8.  Maximizing the healthcare environment: a systematic review exploring the potential of computer technology to promote self-management of chronic illness in healthcare settings.

Authors:  Máirtín S McDermott; Alison E While
Journal:  Patient Educ Couns       Date:  2013-04-06

9.  Patients' perceptions of the negative effects following different prostate cancer treatments and the impact on psychological well-being: a nationwide survey.

Authors:  Ulla-Sisko Lehto; Heli Tenhola; Kimmo Taari; Arpo Aromaa
Journal:  Br J Cancer       Date:  2017-02-21       Impact factor: 7.640

10.  A multimedia interactive education system for prostate cancer patients: development and preliminary evaluation.

Authors:  Michael A Diefenbach; Brian P Butz
Journal:  J Med Internet Res       Date:  2004-01-21       Impact factor: 5.428

View more
  6 in total

1.  Survey of Radiation Oncologists to Assess Interest and Potential Use of a Genetic Test Predicting Susceptibility for the Development of Toxicities After Prostate Cancer Radiation Therapy.

Authors:  Kayla Collado; Sarah L Kerns; Michael A Diefenbach; Elizabeth Peterson-Roth; Raymond Koski; Harry Ostrer; Richard G Stock; Martin Mattessich; Paul Kaplan; Barry S Rosenstein
Journal:  Adv Radiat Oncol       Date:  2020-04-18

2.  Addressing Health Literacy in Patient Decision Aids: An Update from the International Patient Decision Aid Standards.

Authors:  Danielle M Muscat; Jenna Smith; Olivia Mac; Tamara Cadet; Anik Giguere; Ashley J Housten; Aisha T Langford; Sian K Smith; Marie-Anne Durand; Kirsten McCaffery
Journal:  Med Decis Making       Date:  2021-05-29       Impact factor: 2.749

3.  Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial.

Authors:  Donna L Berry; Fangxin Hong; Traci M Blonquist; Barbara Halpenny; Niya Xiong; Christopher P Filson; Viraj A Master; Martin G Sanda; Peter Chang; Gary W Chien; Randy A Jones; Tracey L Krupski; Seth Wolpin; Leslie Wilson; Julia H Hayes; Quoc-Dien Trinh; Mitchell Sokoloff
Journal:  Urol Oncol       Date:  2021-01-19       Impact factor: 2.954

4.  Demographic and Psychosocial Characteristics Associated With Use of a Prostate Cancer Survivorship Website: Implications From a Multisite Randomized Controlled Trial.

Authors:  Allison Marziliano; Michael A Diefenbach; Shawna V Hudson; Erin K Tagai; Elizabeth A Handorf; Alicja Bator; Suzanne M Miller
Journal:  J Med Internet Res       Date:  2022-03-21       Impact factor: 7.076

5.  Clinical Effect of Fuzheng Guben Decoction in the Treatment of Localized Prostate Cancer and Its Influence on Immune Function under Continuous Nursing Intervention.

Authors:  Yanling Zhou; Lan Liu; Lifei Gao
Journal:  Contrast Media Mol Imaging       Date:  2022-09-16       Impact factor: 3.009

6.  A Systematic Review and Meta-Analysis of Patient Decision Aids for Socially Disadvantaged Populations: Update from the International Patient Decision Aid Standards (IDPAS).

Authors:  Renata W Yen; Jenna Smith; Jaclyn Engel; Danielle Marie Muscat; Sian K Smith; Julien Mancini; Lilisbeth Perestelo-Pérez; Glyn Elwyn; A James O'Malley; JoAnna K Leyenaar; Olivia Mac; Tamara Cadet; Anik Giguere; Ashley J Housten; Aisha Langford; Kirsten McCaffery; Marie-Anne Durand
Journal:  Med Decis Making       Date:  2021-06-21       Impact factor: 2.749

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.